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Abstract
Background—This article reports on the methods and framework we have developed to guide 
economic evaluation of noncommunicable disease registries.
Methods—We developed a cost data collection instrument, the Centers for Disease Control and 
Prevention’s (CDC’s) International Registry Costing Tool (IntRegCosting Tool), based on 
established economics methods We performed in-depth case studies, site visit interviews, and pilot 
testing in 11 registries from multiple countries including India, Kenya, Uganda, Colombia, and 
Barbados to assess the overall quality of the data collected from cancer and cardiovascular 
registries.
Results—Overall, the registries were able to use the IntRegCosting Tool to assign operating 
expenditures to specific activities. We verified that registries were able to provide accurate 
estimation of labor costs, which is the largest expenditure incurred by registries. We also identified 
several factors that can influence the cost of registry operations, including size of the geographic 
area served, data collection approach, local cost of living, presence of rural areas, volume of cases, 
extent of consolidation of records to cases, and continuity of funding.
Conclusion—Internal and external registry factors reveal that a single estimate for the cost of 
registry operations is not feasible; costs will vary on the basis of factors that may be beyond the 
control of the registries. Some factors, such as data collection approach, can be modified to 
improve the efficiency of registry operations. These findings will inform both future economic 
data collection using a web-based tool and cost and cost-effectiveness analyses of registry 
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operations in low- and middle-income countries (LMICs) and other locations with similar 
characteristics.
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1. Introduction
Worldwide, noncommunicable diseases (NCDs) account for 43% of the disease burden, and 
this is expected to increase to 60% by 2020 [1]. Much of this increase will result from the 
projected growth in NCDs in low- and middle-income countries (LMICs) [2]. Large 
inequities exist in the coverage and quality of registration activities across the world, with 
limited information currently available in the lower-income settings. Although historically 
there have mostly been hospital-based cancer registries which collect information on 
admitted cases, there are very few longstanding population-based registries [2]. The U.S. 
Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries 
funds cancer registries in Puerto Rico and Pacific Island Jurisdictions which may have 
similar characteristics to those funded in LMICs. The percentage of the population covered 
by cancer registries that meet the quality standards for inclusion in global statistics (Cancer 
Incidence in Five Continents, or CI5) ranges from nearly 100% in North America to less 
than 10% in Asia, Central and South America, and Africa, where most LMICs are located. 
The stark reality is that the burden from NCDs is increasing in LMICs [2,3]. Without 
detailed local information on the incidence, effectiveness of prevention interventions, 
treatment outcomes, and mortality, the evidence base to support prevention and control 
activities is limited. Investing in high-quality registry data is essential in LMICs to inform 
data-driven selection of interventions to ensure efficient use of available funds and optimize 
health benefits.
Economic evaluations of surveillance operations are now increasingly important as decision 
makers identify the funding required to initiate and sustain NCD registry operations. 
Additionally, cost data are required to evaluate the most-efficient approach and process for 
collecting surveillance data, and to quantify the resources needed for program activities. 
Although the generalized methodology for collecting cost data from programs has been well 
described [4–12], there is limited information on the optimal approaches to collecting cost 
and resource use data from registries [13–17]. Specifically, there is no systematic and tested 
approach to collecting economic data from registries operating in different regions of the 
world and in countries with a variety of income levels. Standardized methodology for 
collecting cost data is essential for performing comparative economic evaluations that can 
provide actionable feedback to policy makers [18,19].
To be successful and provide high-quality data, surveillance and registration operations 
require several components, including case ascertainment, data abstraction, database 
management, and dissemination of findings. In addition to these core activities, registries 
also need support functions such as management, training, and information systems. 
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Therefore, to allow for comprehensive evaluations, economic assessments must collect 
detailed costs related to each activity; preparation of justifications for decision makers about 
the need for additional dollars to support activities and/or planning interventions to optimize 
costs are not feasible when only information on total cost is available [16,18,20]. 
Furthermore, comparative evaluations require consistent and transparent methods, as costs 
collected from a variety of perspectives, such as funder, program, and society, may not be 
directly comparable [14,15]. A common set of definitions must be available to ensure that all 
costs and resource use can be accounted for systematically.
In this study, we report on the development of a standardized instrument to collect cost data 
from cancer and cardiovascular registries, and we report the results from pilot testing the 
tool to assess the extent to which the tool is able to capture cost data and also the quality of 
the cost data collected. Additionally, we summarize the factors that are likely to impact the 
cost and quality of registry operations. The goal of this analysis is to identify a systematic 
process for collecting, reporting, and comparing cost data on NCD registry operations across 
countries. The findings from this study will establish standardized methodology for 
economic evaluation of registry-based NCD surveillance data collection. The lessons learned 
from pilot testing the tool will help to validate and improve the tool for future cost data 
collection.
2. Materials and methods
We selected a convenience sample of representative population-based registries from low-, 
low–middle-, high–middle-, and high-income countries to pilot test the tool. Our goal was to 
select established, early-phase, and research-focused registries in geographically dispersed 
locations (urban and rural areas). On the basis of these criteria, we invited 11 registries from 
multiple countries including India, Kenya, Uganda, Colombia, and Barbados to pilot test the 
tool. The Mumbai (India), Nairobi (Kenya) and Kampala (Uganda) registries are all 
established registries in predominantly urban locations. The Barshi (India) and Eldoret 
(Kenya) registries are both more research-focused, with a rural and rural-urban coverage 
area, respectively. In Colombia, we worked with 5 established registries across the country: 
the Barranquilla, Bucaramanga, Cali, Manizales, and Pasto registries. The cancer registry in 
Barbados is classified as an early-phase registry, as it is still in the process of establishing an 
optimal data collection approach for cancer case data collection. The Barbados registry is 
also unique in that the cancer, stroke, and heart attack registries are housed together.
2.1. Developing the IntRegCosting tool
We performed in-depth case studies and interviews during site visits to each registry to 
ensure that the cost data elements included in the CDC’s International Registry Costing Tool 
(IntRegCosting Tool) were comprehensive. Each registry completed a detailed Pre-Site Visit 
Questionnaire that provided information on the registry structure and operations, which 
allowed us to understand the optimal approach to collect and allocate cost data to registry 
activities. During the site visit, we clarified the details provided in the Pre-Site Visit 
Questionnaire and performed key informant interviews to understand the data collection 
process, procedures for developing analytic files, and activities involved in disseminating the 
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registry data. This qualitative information was analyzed to identify common themes and then 
these themes were used to determine the list of activities related to registry operations and 
their definitions. Additionally, through these qualitative interviews, we gathered information 
on barriers and facilitators as well as factors that affect the cost and effectiveness of registry 
operations. In the future, when data are available from a much larger sample of cancer 
registries, we will use these factors to perform in-depth univariate and multivariate analysis 
to assess impact of the factors on cost of registry operations
The overall structure of the IntRegCosting Tool is based on the economic evaluation data 
collection tool developed for the Centers for Disease Control and Prevention’s National 
Program of Cancer Registries (NPCR) in the United States [15]. We modified and adapted 
the NPCR tool for use in the non-U.S. setting on the basis of input received from the NCD 
registries through the Pre-Site Visit Questionnaire and the qualitative staff interviews. The 
methods used to guide our adaptation of the NPCR data collection instrument to create the 
IntRegCosting Tool were based on standard methods of collecting program cost data [4,5,9]. 
We subdivided the IntRegCosting Tool into 10 modules to collect the activity-based resource 
use and cost information (Table 1). We attempted to design the IntRegCosting Tool modules 
to reflect budget categories familiar to management and fiscal staff at the registries so as to 
minimize any ambiguity in the data elements requested in each module. The tool collected 
data across budget categories, including labor; consultants; computers, travel, training, and 
other materials; software; and administrative or overhead expenses. The first nine modules 
include (1) registry details, such as name, organization type, and structure; (2) total 
expenditures from all sources of funding; (3) in-kind contributions; (4) personnel 
expenditures; (5) personnel activities; (6) consultant expenditures; (7) computers, travel, 
training, and other materials expenditures; (8) software used and licensing expenditure; and 
(9) administrative expenditures.
To supplement the cost data, the final module in the IntRegCosting Tool (module 10) 
collected information on selected factors that can affect the cost, effectiveness, and quality of 
registry operations. To reduce duplication of effort, we collected only details on factors that 
were not readily available from other reliable sources such as size of coverage area. We 
obtained information in the tool on total number of incident cases, total number of abstracts 
received, and methods of data reporting.
The IntRegCosting Tool is designed to collect data using the activity-based costing 
methodology. Therefore, in each of the modules, we requested that the registries allocate 
each expenditure to specific registry activities [15–18]. A listing of the 27 registry activities 
is shown in Table 2, categorized into fixed- versus variable cost-activities. Detailed activity 
definitions are provided in Appendix A. We defined fixed-cost activities as those that do not 
vary in cost as volume of cases change (at least in the short run), and variable-cost activities 
as those that do. The variable cost-related activities were further subdivided into core 
activities—those that are essential for registry operations—and other activities, such as 
enhanced analysis and research-related tasks. The registries were asked to allocate the time 
spent by each registry staff so labor costs could be estimated for each of the 27 activities. 
The tool, based on prior experience in collecting cost data from programs, provides up to 
three activity choices to allocate cost related to other non-labor expenditures.
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The IntRegCosting Tool collects cost data using a programmatic perspective. Registries 
often pool funds from multiple sources, so a direct correlation between registry activity and 
funding stream is not always possible. Therefore, the tool is designed to generate activity-
based cost regardless of the funding source used to pay for registry expenditures. 
Furthermore, to ensure comparability across registries, the IntRegCosting Tool also collects 
data on in-kind labor and non-labor contributions. In-kind contributions include non-
monetary resources, assistance, and support provided to the registries—for example, 
voluntary time spent by clinicians and researchers to develop registry policies or advice on 
specific cases that require manual review. Non-labor contributions include office space, 
phone service, water, electricity, and supplies, which are often contributed by the host 
institution (for example, the university, research institute, or cancer society where the 
registry is hosted). Distortions in program cost estimates have been shown to occur if these 
in-kind contributions are not included [13–15].
The IntRegCosting Tool allows a registry director or representative to self-report registry 
cost information for a specific fiscal or annual period. The tool was created in Microsoft 
Excel because the spreadsheet capabilities of Excel facilitate data checks during the data 
entry process and because Excel allows the insertion of formulas to calculate totals for each 
cost category automatically. The Excel-based IntRegCosting Tool and user’s guide has self-
guided check posts to ensure the tool was completed accurately. Check posts include 
confirmation that (1) funding information is provided in module 2 for the reporting year; (2) 
in-kind contributions are only entered in module 3 for the reporting year; (3) salaries entered 
in module 4 are the total annual or fiscal period salaries earned by staff members and not 
only the amounts related to registry activities; (4) only payments made for consultant 
services during the reporting time period are reported in module 6; and (5) information in 
module 10 is based on cases diagnosed in the appropriate year.
2.1.1. Country-Specific adjustments and language translation—The 
IntRegCosting Tool and user’s guide were tailored when needed to ensure incorporation of 
that terminology specific to each country’s understanding of terms and procedures. These 
country-specific changes were generally related to wording of definitions. The overall 
activity categories remained the same to allow for comparison across registries and 
countries. To further facilitate data collection, the IntRegCosting Tool and user’s guide were 
translated into Spanish; however, we used the same broad standardized activity-based 
costing approach for both language versions. The English tool and user’s guide were 
translated into Spanish by professional translators and then reviewed by Spanish-speaking 
registry collaborators to ensure clarity of the language used. All other aspects of the data 
collection, including modules, data elements, and activities, remained consistent across the 
English and Spanish versions of the tool.
2.1.2. Cancer and cardiovascular registry cost data collection—To accommodate 
data collection from organizations that host multiple integrated registries, we embedded a 
few modifications in the tool. In each module, we allowed organizations to select activities 
specific for each registry. When there were shared expenditures across registries, we 
provided an option for reporting the proportion of the cost that need to be allocated to each 
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specific registry. For example, when labor was shared, the time spent on each registry 
activity was used to assign proportion of cost. For rental cost of shared space, the 
proportional cost was based on the number of square feet used.
2.1.3. Data collection using the IntRegCosting tool—The data collection needed to 
identify the activities required to collect high quality cancer data and the resources needed to 
support these activities was incidental to the primary intent of providing technical assistance 
to support registries. Before initiating data collection, we held introductory conference calls 
with all registries, which were followed by interactive webinar-based training sessions. 
Additionally, we provided registries with the user’s guide, which contained detailed 
instructions and definitions for reporting the required data. We also provided technical 
assistance throughout the data collection period via telephone and email to ensure accuracy 
and completeness of the costing information. Each registry provided cost data 
retrospectively for the annual period that best matched the program budgeting period from 
January 2013 through March 2015.
3. Calculation
3.1. Analytic file creation
We reviewed data provided by the registries for internal consistency, using descriptive 
statistics to review cost by budget category and by comparing the expenditures reported in 
the tool to the total funding received. Using the details provided in the IntRegCosting Tool, 
we also generated activity-based cost estimates. For instance, labor hours allocated to 
specific registry activities were multiplied by hourly wage for each registry personnel to 
derive labor cost allocated to the activity. Labor and non-labor costs allocated to each 
activity were summed to derive total cost of each registry activity. In-kind contributions were 
also assigned in a similar manner. Any potential discrepancies identified were clarified with 
registry staff before finalizing the data inputs. We created both registry-specific and 
combined data files to assess distribution of cost by budget and activity categories. All 
analyses were performed using local currency units. To allow for comparability across the 
registries, we present percentage distribution across budget categories and cost expended by 
fixed and variable cost activity categories. Only cost and resource use data from cancer 
registries are presented.
3.2. Data quality assessment
We performed a series of data quality checks to assess the feasibility of using the 
IntRegCosting Tool to collect data for economic assessments. First, we determined whether 
the total cost of specific activities that received direct monetary contributions matched the 
total amount of funding received. When assessing the quality of the cost data submitted, we 
considered data “acceptable” for generating high-quality data if 90% of costs or more were 
allocated to specific activities. Second, our a priori expectation, based on past evaluation of 
registry activities, was that the majority of the funds would be spent on labor [15,21]. To 
confirm this, we generated cost estimates for the following budget groupings: labor; 
consultants; computers, travel, training, and materials; and indirect, administrative, and 
software. Although the general approach in economic assessments is to use an appropriate 
Subramanian et al. Page 6
Cancer Epidemiol. Author manuscript; available in PMC 2018 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
allocation methodology to assign indirect costs to program activities [4], we chose to present 
administrative or indirect costs as a separate cost center to ensure that these costs were 
indeed reported by all sites. This approach also allowed us to compare the magnitude of the 
indirect or administrative cost data across the registries. Third, we assessed whether the 
information reported in the IntRegCosting Tool allowed us to generate activity-based costs 
for all registry activities. That is, we identified whether costs were systematically omitted for 
specific registry operations.
4. Results
Table 3 provides an overview of the characteristics of the 11 registries that were selected to 
pilot test the IntRegCosting Tool. Overall, the registries varied substantially in terms of 
general characteristics, including size of population covered, number of reporting sources, 
and data collection approach (whether paper or electronic). Cancer was a reportable disease 
for about a third of the registries, and approximately half of the registries performed active 
follow-up. Additionally, nearly half of the registries collected data on nonresident cases to 
share with neighboring registries, and about a third performed death clearance to verify 
deaths. We used ‘inclusion in CI5′ as a proxy for quality of the cancer registry data; two-
thirds of the registries generated data that was deemed to be of high enough quality to be 
included in global cancer statistics in CI5. Registry staffing also varied widely, reflecting the 
mix of both very small and very large registries. For instance, full-time data collection staff 
ranged from 1 to 17 across the 11 registries.
Fig. 1 presents the distribution of cost among the cancer registries by budget categories. 
These costs include both monetary contributions and in-kind contributions; much of the 
nonmonetary support was provided by the host institutions where the registries were based. 
All registries met the threshold for high-quality economic data in that we were able to 
allocate more than 90% of the financial contributions received to specific registry activities. 
Labor was the largest cost component for all registries, ranging from 53% to 93% of the 
total cost. All registries were able to accurately report labor costs by reviewing salaries paid 
to staff, regardless of the source of the funding for the salary, whether from the host 
institution or external funds. Consultants were seldom used, and their payments could be 
tracked and accurately reported by registries except when in-kind contributions were 
involved. In those instances, to estimate the monetary contribution of the in-kind labor, hours 
were estimated, and appropriate salaries were assigned to the individual on the basis of level 
of training and experience. Overall, consultants represented a very small amount of the 
registry resources.
Costs associated with computers, travel, training, and materials could be linked to specific 
events or purchases for which documentation was generally available to verify expenditure. 
Costs associated with indirect or administrative support and software were most often 
contributed by host institutions, and as there were no direct transfers of funds, these costs 
were the most difficult to accurately estimate. The registry staff reviewed internal documents 
when feasible and sought support from financial teams in their institutions to provide the 
best possible estimation of these costs.
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Table 4 provides the mean proportion and range of resources allocated to the fixed-cost 
activities and the two variable-cost activity categories. All registries were able to report costs 
related to the key fixed-cost activities and the core variable-cost activities, thus providing 
additional validation of the accuracy of the data collected through the IntRegCosting Tool. 
On average, fixed-cost activities accounted for a third of the total cost, and core variable-cost 
activities were half of the registry operating cost. The ranges, reported in Table 4, show large 
variations across the registries.
Table 5 summarizes the key findings from the qualitative interviews on the factors that could 
impact the cost and quality of the registry data. We identified a large number of factors, 
related to both internal registry operations and external aspects, which need to be considered 
when performing economic evaluations of registries. Some of the internal factors may be 
amenable to modification by registry staff, but not consistently. For example, registry staff 
can take steps to increase the amount and continuity of the funding, but the overall 
availability of funds can hamper their efforts. External factors are generally beyond the 
control of the registry and could explain the reasons for variation in cost. The geographic 
area covered by the registries and the number of reporting sources will affect the number of 
data collectors required and thereby affect the cost of the registry operations. Other, subtler 
aspects that can affect cost and quality of the data include the support infrastructure available 
in terms of trained personnel, and availability of high-quality data at the collection sites.
5. Discussion
Overall, the registries were able to use the IntRegCosting Tool to assign operating 
expenditures to specific activities. We were able to verify the completeness of the costs 
derived from the IntRegCosting Tool for activities that were funded directly through external 
sources or those that were provided through transfer payments, such as salaries, from the 
host institutions. Although the registries were able to use the user’s guide and technical 
support provided to estimate the cost of non-labor activities, we are not able to 
systematically assess the accuracy of the cost of the indirect administrative support and other 
in-kind contribution provided by the host institution. These costs, such as use of office 
space, do not involve any direct transfer payments, and we had to use best-case estimates to 
derive these costs based on standard economics methodology [4,5]. On the basis of prior 
registry evaluations, we know that labor cost typically is the largest source of registry 
expenditure; for example, labor cost accounted for 79% of the total cost in European 
registries [21]. In this study, labor costs were derived to a high level of accuracy, as they 
were based on actual payments made to registry staff or consultants. The registries were able 
to use the IntRegCosting Tool to successfully allocate costs to specific registry activities. 
More than 90% of the total costs were assigned to specific activities, and on average, a third 
of the costs were expended on fixed cost registry activities. A detailed comparison of 
registry characteristics, cost per case, and cost per inhabitant is provided in Tangka et al. 
[22].
Findings from the pilot study show that there are many different factors that affect cost of 
registry operations. This is similar to conclusions from previous analyses of the economics 
of registry operation in both the United States and Europe [13–17,21,23]. In the recently 
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completed economic evaluation of the NPCR, volume of cases was shown to be an important 
determinant of cost, and costs for low-volume versus high-volume registries were US $38 to 
US $135 per case collected, respectively [13]. We have reported in this manuscript and in 
past studies on several factors that can affect registry costs [15]. These include the size of the 
area served, the urban/rural makeup of the area served, and the data collection approach 
including extent to which active follow-up is performed.
The many factors identified most likely interact in complex ways, and therefore, their impact 
on cost of operation is not a straightforward association. For example, past analysis has 
revealed the existence of economies of scale, which exhibit a non-linear relationship. In 
addition, although volume is a critical factor in lowering cost per case, other cost drivers 
need to be considered [14]. Thus, it is not feasible to derive a single cost estimate for registry 
operations, but one can use the factors identified to determine the anticipated cost of running 
specific registries on the basis of both internal registry operations and external features. In 
future research, using a larger sample of cancer registries, we will determine the extent to 
which factors identified in this study decrease or increase registration costs to develop a cost 
estimation algorithm to project registry operational costs.
Another key finding is that although many of the factors identified may be beyond the 
immediate control of registry staff, especially factors external to the registry. Several of the 
internal registry operational characteristics can be modified to improve efficiency. For 
example, adoption of improved data collection approaches, such as electronic data collection 
that eliminates manual entry of information into the registry database, could help reduce 
staff time and hence decrease expenditure within the largest cost component of the registry 
operations. Additional research is needed to develop the evidence base on optimal 
approaches to improve efficiency and cost-effectiveness of the operations. These 
investigations could determine both enablers and barriers to producing actionable guidance 
for registries, and they could also assess the potential benefit of tailoring the design of the 
interventions based on existing registry infrastructure.
The IntRegCosting Tool collected cost data retrospectively from the 11 registries in this 
study. Although retrospective data can be subject to recall error, we believe recall error had 
minimal effect on our results, in part because registries maintain detailed records on 
employee compensation, the largest component of overall registry costs. To ensure accurate 
allocation of labor costs, we asked that all staff members report the proportion of time they 
spent on specific registry activities. In addition, most staff members worked on few 
activities; therefore, the potential for recall error was minimal. The accuracy of the 
information in terms of allocation of cost to specific activities, however, could not be 
verified in this study, which is a potential limitation. We did provide the sites with a detailed 
user’s guide that contained descriptions of all activities, and we provided further clarification 
via conference calls. We believe this hands-on approach facilitated accurate allocation of 
resources and cost to program activities. The IntRegCosting Tool is designed to be 
completed primarily by registry directors (or designees) with assistance from fiscal staff as 
required. Such reliance on a few key informants has been shown to be a reliable approach to 
collect cost data from programs and to significantly reduce the resources expended on data 
collection [24]. In future data collection efforts, the IntRegCosting Tool can be used to 
Subramanian et al. Page 9
Cancer Epidemiol. Author manuscript; available in PMC 2018 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
collect information about labor time related to specific project activities in a prospective 
manner. Additionally, data collection from a larger number of diverse registries will assist in 
further verifying the ability of the IntRegCosting Tool to collect activity-based cost data.
While pilot testing the IntRegCosting Tool, we identified a few ways in which the 
IntRegCosting Tool could be improved. First, more-detailed definitions and systematic 
approaches to calculate in-kind support, especially host registry contributions, can be 
provided. During the pilot testing process, technical support was provided to assist the 
registries in using an appropriate estimation approach based on established economics 
methodology. Lessons learned from the pilot testing can be used to provide detailed 
guidance on specific types of contributions, methodology to estimate cost, the data elements 
required to calculate costs, and approaches to confirm assumptions through sensitivity 
analysis. Furthermore, formulas can be embedded in the tool to improve ease of use and 
accuracy.
Second, to reduce the effort required to manually review completeness and overall accuracy 
of the results, an automated process can be implemented to verify information interactively 
so errors can be addressed during the initial data input process. This process will reduce 
overall time required by the registries to verify and input data after the initial data 
submission. Third, we received feedback from registry staff on their desire to use the 
IntRegCosting Tool features to inform registry planning through the use of scenario analysis. 
For example, staff would like to use the tool to answer questions such as, “What is the 
optimal approach and cost for expanding registry operations to cover a large population 
base?” The web-based tool currently in development will incorporate this feature and 
contain modules to allow registries to project future cost of changes to registry operations. 
Fourth, to capture a full set of potential factors that can affect cost of operations and explain 
differences between registries, we will include additional factors that may affect cost and 
effectiveness that have been identified through the pilot study.
6. Conclusion
The detailed, activity-specific cost data collected via the IntRegCosting Tool can help 
registries in LMICs understand the cost of their operations, design approaches to improve 
efficiency, and provide standardized data to compare with other registries, such as NPCR-
funded cancer registries. For example, registries in Colombia have used the costing results to 
compare their activity-based costs to assess activities with large variation in order to perform 
follow up assessments to determine the drivers of these differences. Results from the pilot 
test indicated that the IntRegCosting Tool can be used to collect detailed, high-quality cost 
data with minimal burden to registries in LMICs. Although we tested the tool with cancer 
and cardiovascular registries, the activity categories and overall approach are applicable to 
other types of chronic disease registries. Cost data collected with a standardized tool will 
allow existing registries to improve economic efficiency of operations and provide guidance 
on the funding and design of new registries. The tool can also be used to create a continual 
learning environment where activities of the registries are assessed at regular intervals to 
track operation metrics in terms of both the cost and the quality of the data reported. In the 
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future, scenario analytics will also be embedded in the IntRegCosting Tool to perform cost-
effectiveness assessment of various data collection approaches and other registry operations.
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Appendix A. IntRegCosting Tool: Listing of Registry Activities and 
Definitions
Management
Registry management, including, but not limited to, addressing personnel and staffing issues, 
and preparing registry applications for funding requests
Administration
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Mailing, filing, logging, and other clerical tasks
Training of Registry Staff
Training of central registry staff; providing educational opportunities for staff; registry staff 
attending training-focused workshops and meetings, webinars, conference calls, and other 
state and local training opportunities
IT Support
Activities including, but not limited to, software management and support, hardware 
upgrades, network maintenance, and creation new systems and interfaces
Reporting Requirements
Preparing documents to disseminate registry statistics (including mandated and voluntary 
reporting) and providing data for inclusion in national and international databases
Outreach
Visiting schools and other locations to increase awareness about disease registration to 
support data collection efforts. Other activities could include providing continuing medical 
education to health professionals on the importance of disease registration
Liaising with Stakeholders
Serving as liaison to national partners, funders (health ministry, etc.), international agencies, 
cancer registries, and other organizations
Case Ascertainment
Using the CanReg4 or CanReg5 [25] Person Search function to determine if a patient is 
already in the database, and if so, whether the current data duplicates existing information or 
documents a new primary tumor. Also includes processing pathology reports and following 
up with physicians and other health care providers
Death Certificate Clearance
Confirming mortalities with local Registrar of Births and Deaths
Data Collection and Abstraction
Collecting information from hospitals, nursing homes, medical labs, and diagnostic and 
treatment centers
Data Entry
Entering abstracts into CanReg4, either manually or via upload
Coding
Coding into databases or statistical programs for analysis
Data Validation
Running checks to verify data quality including the CanReg4 functions Check Status for 
manual entry and Do Checks for imported data
Developing Analytic Files
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Developing methods for matching cases, determining match criteria and categories of 
matching, consolidating data, and so on
Database Management
Managing datasets for registry operations and special studies, including backing up data and 
performing other functions using the Management option in CanReg4
Data Analysis and Reporting/Tabulation
Performing descriptive and statistic data analysis and generating tables using the CanReg4 
Analysis sub-menu
Quality Assurance
Activities that include, but are not limited to, performing computerized and visual edits, 
reconciling discrepancies between cases, creating guidelines for data consolidation, and 
performing re-abstracting audits
Sharing Cases (with other registries)
Activities that include, but are not limited to, creating data sharing agreements, preparing 
and submitting cases for data sharing, and importing and editing incoming cases from data 
sharing sources
Developing Proposals for Funding
Writing and submitting proposals to different sources to receive funding or grants
Electronic Case Reporting and Data Encryption
Maintaining and increasing electronic case reporting from health care providers, including 
encrypting data
Automatic Case Finding Using Electronic Linkages
Linking to electronic data sources and finding cases automatically through such linkages
Linking Records to Other Databases (e.g., death certificate data)
Creating and submitting data files to reporting agency as specified for matching and linking, 
incorporating linked records into the registry’s data management system, procuring 
additional incoming data sources, importing cases from linked data sources, and performing 
visual review and updating cases from linked sources
Training of Others by Registry Staff
Training medical records officers and other health data reporters as part of continuing 
education and other activities where registry staff members train those not working at the 
central registry. This includes answering quality assurance questions and material 
development
Implementing an Inquiry Response System
Answering requests for data and other inquiry response system activities
Research Studies and Advanced Analysis Using Registry Data
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Investigating disease clusters, performing special studies, and other research and analysis 
using registry data
Publication of Research Studies Using Registry Data
Preparing research studies resulting from registry data for publication
Active Follow-Up
Performing active, rather than passive, follow-up as necessary
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Fig. 1. 
Registries’ Resources by Budget Categories.
Note: For the Nairobi Cancer Registry, Kenya, we show the average cost results using data 
collected for July 2012–June 2014. For all other registries, we show results from the first 
round of data collection for the following periods: Kampala Cancer Registry, Uganda – 2014 
annual cost data; Mumbai Cancer Registry, India – fiscal year 2014–2015 cost data; 
Barranquilla, Bucaramanga, Cali, Manizales, and Pasto Cancer Registries, Colombia – 2013 
annual cost data; and Barbados Cancer Registry – April 2014–March 2015.
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Table 1
Overview of Modules in the IntRegCosting Tool.
Module Description Data Elements
Registry details General registry information Registry name, organization type (health department, 
university, research institute, private, other), primary 
contact person
Expenditures Total spending for the program year from all 
funding sources
Total funds by source, total funding for current year, 
unobligated funds carried forward from previous year, 
amount of funds unspent for the current year, total funds 
expended
In-kind contributions Nonmonetary resources, assistance, and 
support
Labor contributions, non-labor contributions, valuation 
method, primary activity
Personnel expenditures Personnel expenditures related to registry 
activities
Job title, full-time equivalent percentage, number of hours 
per week, months employed in fiscal year, salary, 
percentage of total time spent on all registry activities, 
salary allocated to registry activities
Personnel activities Percentage of employee time spent on 
specific registry activities
Employee percentages by registry activity
Consultant expenditures Value of time spent by contracted 
consultants on registry activities
Job title, annual payment, proportion of time spent on up to 
three activities by each consultant
Computers, travel, training, and 
other materials expenditures
Costs associated with computers, travel, 
training and other materials
Hardware costs, IT support costs, travel costs, training fees, 
costs of other materials, primary activity associated with 
costs, cost calculation method (actual, estimate, other)
Software used and licensing 
expenditure
Costs associated with software licensing and 
other software packages used by registries
Name of software, total amount of contract, year contract 
started, length of contract, amount paid in current year, cost 
calculation method (actual, estimate, other)
Administrative expenditures Expenditures for administrative and 
overhead costs (e.g., phone, rent)
Total administrative or overhead cost; allocation method 
(e.g., percentage of direct costs); sub-category totals—rent, 
repairs/maintenance, network connection/maintenance, 
phone service, office equipment, other costs (such as water 
and electricity bills)
Factors affecting registry 
operations
Supplemental information on factors that 
may affect the costs of registry operations 
and effectiveness
Incident cases, abstracts received, whether records were 
stored centrally versus in separate departments, methods of 
data reporting or collection, data collection process 
(proportion of data abstracted directly from hospital 
records by registry staff or hired contractors), non-resident 
cases reported
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Table 2
Fixed- and Variable-Cost Registry Activities.
Fixed-Cost Registry Activities
Management Reporting requirements
Administration Outreach
Training of registry staff Liaising with stakeholders
IT support
Variable Cost: Core Registry Activities
Case ascertainment Data validation
Death certificate clearance Developing analytic files
Data collection and abstraction Database management
Data analysis and reporting/tabulation
Data entry Quality assurance
Coding Sharing cases
Variable Cost: Other Registry Activities
Developing proposals for funding Implementing an inquiry response system
Electronic case reporting and data encryption Research studies and advanced analysis using registry data
Automatic case finding using electronic linkage Publication of research studies using registry data
Linking records to other databases Active follow-up
Training of others by registry staff
Cancer Epidemiol. Author manuscript; available in PMC 2018 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Subramanian et al. Page 19
Table 3
Registry General Characteristics, Activities, and Staffing.
General Characteristics Range
Years of operation 9 – 62
Population covered 277,814 – 17,443,311
Square kilometers covered 121 – 11,820
Proportion of data reporting by paper 30% – 100%
Number of reporting or data sources 12 – 180
Incident casesa 300 – 19,485
Registry Activities Percentage of Registries
Reportable disease 36%
Perform active follow-up 55%
Collect and report nonresident cases 45%
Perform death clearance 36%
Included in Cancer in Five Continents (CI5) 64%
Registry Staffing (Full Time Equivalents) Range
Management and administrative staff 1–3
Registrars and data collectors 1–17
Database management and IT support staff 0–8
Researchers, investigators, and medical personnel 0–3
a
Full year incidence estimates were used for registries with continuous ongoing data collection while ‘best-estimate’ averages were used for all 
others (specifically registries in Nairobi and Barbados where cases collected varied between annual periods).
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Table 4
Proportion and Range of Resources by Registry Activity.
Fixed-Cost Activities Variable Cost—Core Registry Activities Variable Cost—Other Registry Activities
Mean 33.8% 51.5% 14.7%
Range 19.3%–62.0% 37.1%–66.9% 0.9%–24.3%
Note: The means and ranges represent registry cost results for the following periods: Nairobi Cancer Registry, Kenya – July 2012–June 2014, 
Kampala Cancer Registry, Uganda – 2014 annual cost data; Mumbai Cancer Registry, India – fiscal year 2014–2015 cost data; Barranquilla, 
Bucaramanga, Cali, Manizales, and Pasto Cancer Registries, Colombia – 2013 annual cost data; and Barbados Cancer Registry – April 2014–
March 2015.
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Table 5
Factors That Affect Registry Cost and Data Quality.
Affects Cost Affects Quality Comments
INTERNAL REGISTRY OPERATIONS
Organization and funding structure 
(host institution support versus 
external funding)
X X Continuity of funding and adequate level of resources are essential for 
planning and implementing efficient processes
Data collection procedures (paper 
versus electronic format)
X X Electronic data collection reduces data reentry time and can improve 
quality
Number and types of data 
elements collected
X X Collection of treatment and outcomes data (including use of active 
follow-up procedures) increases the cost but can improve quality of 
the data available
Staff turnover and training 
requirements
X X Employing staff on short-term contracts because of funding 
limitations can lead to high staff turnover and the need for repeat 
training sessions, which increases cost and reduces quality
Work mix (core data collection 
versus research activities)
X X Research activities tend to be more data intensive and can increase 
staff time required to collect and report registry data
Data exchanged, caseload, and 
reporting of nonresident cases
X X Collecting nonresident data increases cost, but receiving cases from 
other registries can improve completeness of registry data
EXTERNAL FEATURES
Total volume of cases X Data abstraction cost increases with volume; fixed costs do not
Number of reporting sources X A larger number of sources increases time required to travel and 
obtain records at multiple facilities
Number of abstracts versus 
incidence cases
X Even when electronic processes are available to ensure unduplicated 
records, some manual review will be required
Size of area served and presence 
of rural areas
X Large areas lead to high travel costs to facilities because of long 
distances and an increase in staff time related to travel
Availability of trained personnel X X Shortage of personnel can increase cost, because of intensive training, 
and reduce quality
Cost of living in geographic 
location
X Labor cost will vary on the basis of cost of living
Quality of facility reporting and 
presence of hospital-based 
registries
X X Ease of access (centralized versus decentralized records) and 
completeness of data at the facilities can improve data collection 
efficiency and quality
Case reporting mandated by law 
(reportable disease)
X X Mandatory case reporting reduces time required to negotiate with 
providers, improves access to the data, and also improves case 
ascertainment
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